Evolva is pleased to announce that the findings on bone mineral density of postmenopausal women in the RESHAW (Resveratrol Supporting Healthy Aging in Women) clinical study have been peer-reviewed and published in the Journal of Bone and Mineral Research. The report, “Regular Supplementation with Resveratrol Improves Bone Mineral Density in Postmenopausal Women,” is the second in the series of anticipated publications from the extensive two-year RESHAW clinical trial of Veri-te™ resveratrol in 125 postmenopausal women. Link to article